Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer

Cancer Investigation

Volumn 26, Issue 5, 2008, Pages 464-470

  Schmitz, Volker ^a   Raskopf, Esther ^a   Gonzalez Carmona, Maria Angeles ^a   Vogt, Annabelle ^a   Kornek, Miroslaw ^a   Sauerbruch, Tilman ^a   Caselmann, Wolfgang H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Angiostatic effects; Antitumor effects; Lung cancer; Plasminogen derivatives

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; PLASMINOGEN DERIVATIVE K1 4; PLASMINOGEN DERIVATIVE K1 5;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HUMANS; KRINGLES; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN; RECOMBINANT PROTEINS; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 45949107006     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900801970927     Document Type: Article

References (25)

1. Sim, B.K.; O'Reilly, M.S.; Liang. H.; Fortier, A.H.; He, W.; Madsen, J.W.; et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997, 57, 1329-1334.
2. Cao, Y. Therapeutic potentials of angiostatin in the treatment of cancer. Haematologica 1999, 84, 643-650.
3. Yang, D.Z.; He, J.; Zhang, J.C.; Wang, Z.R. Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice. World J Gastroenterol 2005, 11, 4992-4996.
4. Griscelli, F.; Li, H.; Bennaceur-Griscelli, A.; Soria, J.; Opolon, P.; Soria, C. et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 1998, 95(11), 6367-6372.
5. Gyorffy, S.; Palmer, K.; Gauldie, J. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice. Am J Pathol 2001, 159(3), 1137-1147.
6. Indraccolo, S.; Morini, M.; Gola, E.; Carrozzino, F.; Habeler, W.; Minghelli, S. et al. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells. Cancer Res 2001, 61(14), 5441-5446.
7. Schmitz, V.; Wang, L.; Barajas, M.; Peng, D.; Prieto, J.; Qian, C. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen. Gene Ther 2002, 9(23), 1600-1606.
8. Galaup, A.; Magnon, C.; Rouffiac, V.; Opolon, P.; Opolon, D.; Lassau, N. et al. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice. Gene Ther 2005, 12(10), 831-842.
9. Cao, R.; Wu, H.L.; Veitonmaki, N.; Linden, P.; Farnebo, J.; Shi GY et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci USA 1999, 96(10), 5728-5733.
10. Chi, S.L.; Pizzo, S.V. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res 2006, 66(2), 875-882.
11. Veitonmaki, N.; Cao, R.; Wu, L.H.; Moser, T.L.; Li, B.; Pizzo, S.V. et al. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res 2004, 64(10), 3679-3686.
12. Sharma, M.R.; Rothman, V.; Tuszynski, G.P.; Sharma, M.C. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 2006.
13. Magnon, C.; Galaup, A.; Mullan, B.; Rouffiac, V.; Bouquet, C.; Bidart, J.M. et al. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphav-beta3 and alphavbeta5 integrins. Cancer Res 2005, 65(10), 4353-4361.
14. Nestler, G.; Schulz, H.U.; Tautenhahn, J.; Kuhn, R.; Kruger, S.; Lippert, H. et al. Effects of the angiogenesis inhibitor angiostatin on the growth of CC531 colon carcinoma cells in vitro and in a laparoscopic animal model of peritoneal carcinomatosis. Int J Colorectal Dis 2006, 21(4), 314-320.
15. He, T.C.; Zhou, S.; da Costa, L.T.; Yu, J.; Kinzler, K.W.; Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95(5), 2509-2514.
16. Schmitz, V.; Raskopf, E. Plasminogen fragment K1-5 improves survival in a murine HCC model. Gut 2006.
17. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1-2), 55-63.
18. O'Reilly, M.S.; Holmgren, L.; Chen, C.; Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996, 2(6), 689-692.
19. Cao, Y.; Ji, R.W.; Davidson, D.; Schaller, J.; Marti, D.; Sohndel, S. et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996, 271(46), 29461-29467.
20. Cornelius, L.A.; Nehring, L.C.; Harding, E.; Bolanowski, M.; Welgus, H.G.; Kobayashi, D.K. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998, 161(12), 6845-6852.
21. Lucas, R.; Holmgren, L.; Garcia, I.; Jimenez, B.; Mandriota, S.J.; Borlat, F. et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998, 92(12), 4730-4741.
22. Hanford, H.A.; Wong, C.A.; Kassan, H.; Cundiff, D.L.; Chandel, N.; Underwood, S. et al. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. Cancer Res 2003, 63(14), 4275-4280.
23. Stack, M.S.; Gately, S.; Bafetti, L.M.; Enghild, J.J.; Soff, GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J 1999, 340(Pt 1), 77-84.
24. Chen, Y.H.; Wu, H.L.; Li, C.; Huang, Y.H.; Chiang, C.W.; Wu, M.P. et al. Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation. Thromb Haemost 2006, 95(4), 668-677.
25. Raskopf, E.; Dzienisowicz, C.; Hilbert, T.; Rabe, C.; Leifeld, L.; Wernert, N. et al. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 2005, 41(6), 1233-1240.